These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8244168)

  • 1. Secondary cytoreduction in ovarian cancer: pro or con?
    Potter ME
    Gynecol Oncol; 1993 Oct; 51(1):131-5. PubMed ID: 8244168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer.
    Zang RY; Zhang ZY; Li ZT; Cai SM; Tang MQ; Chen J; Liu Q
    Eur J Surg Oncol; 2000 Dec; 26(8):798-804. PubMed ID: 11087649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study.
    Eisenkop SM; Friedman RL; Wang HJ
    Gynecol Oncol; 1998 May; 69(2):103-8. PubMed ID: 9600815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of secondary cytoreduction in the treatment of ovarian cancer: Hacettepe University experience.
    Ayhan A; Gultekin M; Taskiran C; Aksan G; Celik NY; Dursun P; Salman MC; Yuce K; Kucukali T
    Am J Obstet Gynecol; 2006 Jan; 194(1):49-56. PubMed ID: 16389009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: a Gynecologic Oncology Group Study.
    Williams L; Brunetto VL; Yordan E; DiSaia PJ; Creasman WT
    Gynecol Oncol; 1997 Aug; 66(2):171-8. PubMed ID: 9264559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zang RY, Zhang ZY, Li ZT et al. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer. Eur J Surg Oncol 2000; 26:798-804.
    Sugarbaker PH
    Eur J Surg Oncol; 2001 Aug; 27(5):515-6. PubMed ID: 11504529
    [No Abstract]   [Full Text] [Related]  

  • 7. Critical evaluation of secondary cytoreduction in recurrent ovarian cancer.
    Munkarah AR; Coleman RL
    Gynecol Oncol; 2004 Nov; 95(2):273-80. PubMed ID: 15491746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer.
    Munkarah A; Levenback C; Wolf JK; Bodurka-Bevers D; Tortolero-Luna G; Morris RT; Gershenson DM
    Gynecol Oncol; 2001 May; 81(2):237-41. PubMed ID: 11330956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery in ovarian cancer: the concept of cytoreductive surgery.
    Peter A; Heintz M
    Curr Opin Obstet Gynecol; 1996 Feb; 8(1):8-11. PubMed ID: 8777265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary surgical cytoreduction for advanced epithelial ovarian cancer. Patient selection and review of the literature.
    Bristow RE; Lagasse LD; Karlan BY
    Cancer; 1996 Nov; 78(10):2049-62. PubMed ID: 8918397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery of advanced malignant epithelial tumours of the ovary.
    Favalli G; Odicino F; Pecorelli S
    Forum (Genova); 2000; 10(4):312-20. PubMed ID: 11535982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent ovarian carcinoma of low malignant potential: the role of secondary surgical cytoreduction and the prognosis in Chinese patients.
    Zang RY; Yang WT; Shi DR; Xing Y; Cai SM
    J Surg Oncol; 2005 Jul; 91(1):67-72. PubMed ID: 15999350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of CA-125 in the management of patients with recurrent epithelial ovarian carcinoma selected for secondary cytoreduction.
    Mahner S; Woelber L; Jung S; Eulenburg CZ; Ihnen M; Schwarz J; Sehouli J; Jaenicke F
    Anticancer Res; 2009 Jul; 29(7):2817-21. PubMed ID: 19596967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How to increase the optimal rate of secondary cytoreductive surgery in recurrent epithelial ovarian cancer].
    Li YF; Li MD; Liu FY; Liu JH; Li JD
    Ai Zheng; 2003 Nov; 22(11):1193-6. PubMed ID: 14613651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tertiary cytoreduction in patients with recurrent ovarian carcinoma.
    Leitao MM; Kardos S; Barakat RR; Chi DS
    Gynecol Oncol; 2004 Oct; 95(1):181-8. PubMed ID: 15385129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC).
    Cheng X; Jiang R; Li ZT; Tang J; Cai SM; Zhang ZY; Tian WJ; Zang RY
    Eur J Surg Oncol; 2009 Oct; 35(10):1105-8. PubMed ID: 19443175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgery for recurrent ovarian cancer.
    Rose PG
    Semin Oncol; 2000 Jun; 27(3 Suppl 7):17-23. PubMed ID: 10952122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma.
    Chi DS; McCaughty K; Diaz JP; Huh J; Schwabenbauer S; Hummer AJ; Venkatraman ES; Aghajanian C; Sonoda Y; Abu-Rustum NR; Barakat RR
    Cancer; 2006 May; 106(9):1933-9. PubMed ID: 16572412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy.
    Matsumoto A; Higuchi T; Yura S; Mandai M; Kariya M; Takakura K; Fujii S
    J Obstet Gynaecol Res; 2006 Dec; 32(6):580-7. PubMed ID: 17100820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of surgery in ovarian carcinoma.
    Fader AN; Rose PG
    J Clin Oncol; 2007 Jul; 25(20):2873-83. PubMed ID: 17617518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.